LSA
TNDM icon

L & S Advisors’s Tandem Diabetes Care TNDM Stock Holding History

L & S Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,127
Closed -$1.15M – 362
2020
Q3 		$1.15M Buy
10,127
+1,670
+20% +$175K 0.16% 183
2020
Q2 		$837K Sell
8,457
-1,354
-14% -$108K 0.12% 180
2020
Q1 		$631K Buy
9,811
+1,496
+18% +$105K 0.12% 155
2019
Q4 		$496K Sell
8,315
-865
-9% -$53.3K 0.06% 217
2019
Q3 		$541K Buy
+9,180
New +$586K 0.08% 229

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

L & S Advisors's TNDM Position: Q4 2020 in Review

L & S Advisors sold out of Tandem Diabetes Care (TNDM) in Q4 2020, closing a stake of 10,127 shares — an estimated $1.15M sold.

L & S Advisors first reported a position in TNDM in Q3 2019 and held it in 5 quarters. The position peaked at $1.15M in Q3 2020. 309 funds tracked by Wall St. Rank hold TNDM as of Q4 2020.

  • L & S Advisors reported no remaining Tandem Diabetes Care position as of Q4 2020 after selling out during the quarter.
  • L & S Advisors sold 10,127 Tandem Diabetes Care shares in Q4 2020, an estimated $1.15M.
  • L & S Advisors first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 5 quarters.
  • L & S Advisors's Tandem Diabetes Care position peaked at $1.15M in Q3 2020.
  • 309 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2020.

Based on L & S Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.